Scaling cell therapies from early research to clinical manufacturing requires a delivery platform that maintains high cell viability without sacrificing transfection efficiency.
In this 15-minute technology introduction, discover the 4D Nucleofector® LV Unit PRO, our next generation large scale electroporation platform designed to deliver clinically relevant cargos into large volumes of T, NK or CD34+ cells.
Watch this session on-demand and join Shalmica Jackson, Associate Director Market Development and Strategy, as she shares:
- A high-level introduction to the technology and how it works
- Selected data sets demonstrating the platform’s enhanced performance for CRISPR based knock out, knock in, and transposon based integration workflows for T cells
Please fill out the form on the right. We hope you will enjoy the session!
HeadlineBlock(2)
This is a wonderful headline
Lorem Ipsum dolor Consecteur adipiscing elit
Consecteur adipiscing elit
Text(2)
Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim.
HeadlineBlock(3)
This is a wonderful headline
Lorem Ipsum dolor Consecteur adipiscing elit
Consecteur adipiscing elit
Text(3)
Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim.
HeadlineBlock(4)
This is an absolute fabulous headline
WideImg & Text (4)
Text(4)
Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim.
Feat.Guest(1)
Heading H2
Heading H3
Heading H4
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim.
Feat.Guest(2)
Heading H2
Heading H3
Heading H4
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim.
